Payers Quotes

Accountability is the name of the game. The increased emphasis on reimbursement and financial incentives that are tied to performance will place new demands on executives from across the health industry to develop and agree on quality measures. Payers will need to establish systems and processes so that they can evaluate and compare providers. They will need to provide employers with customized data to assist them in managing their health costs. They will rely more heavily on information technology and business intelligence tools to capture, store, retrieve and report quality information.

We continue to be far from that mark here in New Jersey. Once again, a confluence of pressures, ranging from inadequate payments from governmental payers to a growing number of uninsured all contributed to the stagnant bottom lines.

Affordable complementary therapies, such as Diachrome, could make a substantial contribution to lessening the economic burden of diabetes for patients and payers.